Clinical trial
Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC
NCT04144608
Study timeline
Study start (actual)2020-01-16Date precision: day
Registry last updated2024-08-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Non Small Cell Lung Cancerunresolved
Interventions
ToripalimabDRUG · verified · RxNorm: toripalimab
Sponsors & collaborators
Yongchang Zhanglead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04144608 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.